FDA Must Handle Politics Over Female Libido Drug, Docs Say

By Joe Van Acker (July 7, 2015, 5:59 PM EDT) -- The U.S. Food and Drug Administration faces unusual political pressure as it weighs whether to approve a Sprout Pharmaceutical Inc. drug that some call "female Viagra" for its claimed rejuvenation of sexual desire in postmenopausal women, three FDA advisers said in an editorial published Monday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!